US Archives - Page 106 of 157 - European Medical Journal

Strengthening Vaccine Strategies for Mpox

Recent research into monkeypox (mpox) highlights critical gaps in vaccination coverage and infectious disease preparedness, raising concerns about future outbreaks.

LS-SCLC Immunotherapy Treatment Recommended for Approval

A new treatment for limited-stage small cell lung cancer (LS-SCLC) has been recommended for approval in the European Union following positive results from a Phase III trial.

How AI is Simplifying CPR Education

AI is playing an increasingly vital role in the dissemination of medical guidelines, especially in critical areas such as cardiopulmonary resuscitation (CPR).

Prescribing Podcasts For Stroke Recovery

Podcasts are emerging as an innovative solution for patient education, according to an abstract presented at the International Stroke Conference held in Los Angeles, California, USA.

Lung Cancer Screening: Precision versus Simplicity

In the battle against lung cancer, a recent editorial examines the effectiveness of risk prediction models in determining screening eligibility.

Vimentin Autoantibodies Linked to Novel CNS Disorder

A novel autoimmune meningoencephalomyelitis associated with autoantibodies targeting the astrocytic intermediate filament protein vimentin has been identified in a recent case series.

Mechanical Ventilation Elevates AKI Risk in ICU

The association between invasive mechanical ventilation (IMV) and an increased risk of acute kidney injury (AKI) in critically ill patients, with a notable impact on those diagnosed with COVID-19, has been investigated in a recent multicenter study.

Infectious Diseases Experts to Lead The Charge in Healthcare Sustainability

A review article highlights the urgent need for healthcare professionals, particularly those in infectious diseases, to take action in reducing the sector’s substantial environmental impact.

Sex and Age Play Key Role in Pyogenic Granuloma Incidence

A new retrospective study has shed light on the incidence of cutaneous pyogenic granulomas (PGs) by age, sex, and anatomical location.

Apixaban Linked to Fewer Covert Infarcts Post-Stroke

Apixaban has been shown to reduce the risk of nonlacunar covert infarcts in patients who have experienced a recent cryptogenic stroke and have atrial cardiopathy.